ABT · News · 20260821N
CGM Competition and Pricing
ABBOTT LABORATORIES · 2026-08-21 · Importance 20 · Surprise 24
Abbott continues to face competitive and pricing pressure in continuous glucose monitoring. The pressure affects the company's CGM franchise even as demand remains strong across other medical-device categories. Abbott is positioning its glucose-sensing portfolio through broader digital-health and automated-insulin-delivery integrations.
Key facts
- Abbott stated it faces ongoing competitive and pricing pressures in continuous glucose monitoring. source